Infants of Women with Polycystic Ovary Syndrome Have Lower Cord Blood Androstenedione and Estradiol Levels
- 1 May 2010
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (5), 2180-2186
- https://doi.org/10.1210/jc.2009-2651
Abstract
Context: Prenatal androgen excess can cause a phenocopy of polycystic ovary syndrome (PCOS) in mammals. Retrospective studies have suggested that girls at risk for PCOS have low birth weight, and prospective studies have suggested an increased prevalence of small-for-gestational-age offspring in women with PCOS. Objective: The objective of the study was to determine whether infants of women with PCOS have reduced birth weight or increased intrauterine androgen levels. Design: This was a prospective case-control study. Participants: Thirty-nine PCOS and 31 control women and their infants participated in the study. Main Outcome Measures: Birth weight and mixed cord blood testosterone, androstenedione (A), dehydroepiandrosterone, 17-hydroxyprogesterone, estradiol (E2), and dihydrotestosterone levels were measured. Results: Mean birth weight did not differ, but there was a significant increase in the prevalence of large-for-gestational-age infants in the PCOS group. Cord blood E2 and A levels were lower (P < 0.05), but testosterone to E2 ratios did not differ in female PCOS compared with control offspring. There was no difference in E2 and A levels in the male PCOS and control offspring. There was no difference in 17-hydroxyprogesterone or other androgen levels in either male or female PCOS offspring compared with their respective control group. Conclusion: Infants of women with PCOS were more likely to be large for gestational age. Female offspring of affected women have lower cord blood A levels; other cord blood androgen levels do not differ compared with female control offspring. Cord blood E2 levels are also significantly decreased in PCOS, without any difference in the testosterone to E2 ratio, suggesting decreased fetal or placental production of steroids.Keywords
This publication has 40 references indexed in Scilit:
- Associations of Birthweight and Gestational Age with Reproductive and Metabolic Phenotypes in Women with Polycystic Ovarian Syndrome and Their First-Degree RelativesJournal of Clinical Endocrinology & Metabolism, 2010
- Polycystic ovaries after precocious pubarche: relation to prenatal growthHuman Reproduction, 2006
- Treatment with Flutamide, Metformin, and Their Combination Added to a Hypocaloric Diet in Overweight-Obese Women with Polycystic Ovary Syndrome: A Randomized, 12-Month, Placebo-Controlled StudyJournal of Clinical Endocrinology & Metabolism, 2006
- Human Fetal Ovary Development Involves the Spatiotemporal Expression of P450c17 ProteinJournal of Clinical Endocrinology & Metabolism, 2006
- A meta-analysis of pregnancy outcomes in women with polycystic ovary syndromeHuman Reproduction Update, 2006
- Adolescent Girls with Polycystic Ovary Syndrome Have an Increased Risk of the Metabolic Syndrome Associated with Increasing Androgen Levels Independent of Obesity and Insulin ResistanceJournal of Clinical Endocrinology & Metabolism, 2006
- Early Puberty-Menarche After Precocious Pubarche: Relation to Prenatal GrowthPublished by American Academy of Pediatrics (AAP) ,2006
- Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?Human Reproduction Update, 2005
- Birth weight in offspring of mothers with polycystic ovarian syndromeHuman Reproduction, 2005
- Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: What is the best source of information to investigate the effects of fetal hormonal exposure?Hormones and Behavior, 2004